Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1990
12/05/1990EP0400499A2 Medicine containing acylaminoacid derivatives and dietetic products
12/05/1990EP0400486A2 Polyethylene glycol derivatives, modified peptides and production thereof
12/05/1990EP0400477A1 Polymeric anhydride of magnesium and proteic ammonium phospholinoleate with antiviral, antineoplastic and immunostimulant properties
12/05/1990EP0400472A2 Process for preparing polyethylene glycol derivatives and modified protein.
12/05/1990EP0400464A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
12/05/1990EP0400440A1 Amino acid derivative anticonvulsant
12/05/1990EP0400290A1 5-Amino-4-hydroxyvalerianic acid derivatives useful as intermediates in the preparation of renin inhibitors
12/05/1990EP0400077A1 Use of synthetic peptides to generate and manipulate cellular immunity
12/05/1990EP0400075A1 Enhancement of the therapeutic properties of glycoprotein
12/05/1990EP0400051A1 Polypeptide compounds having growth hormone releasing activity.
12/05/1990EP0400047A1 Modified hepatocytes and uses therefor.
12/05/1990EP0400010A1 Soluble human cd4 fragments and uses therefor
12/05/1990EP0378533A4 Method and kit for contraception with gnrh-antagonist and progestin
12/05/1990EP0289587A4 Method for inducing vaginal lubrication
12/05/1990CA2016467A1 Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
12/04/1990WO1990015073A1 Grf peptides
12/04/1990US4975527 Tissue-affinitive collagen for osteogenesis and method of producing the same
12/04/1990US4975526 Packing, washing, swelling the demineralized, quanidine-extracted particles
12/04/1990US4975453 Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
12/04/1990US4975422 Angiogenesis inhibitor
12/04/1990US4975420 Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
12/04/1990US4975419 Tissue irrigating solution
12/04/1990US4975279 7-oxabicycloheptane substituted diamide prostaglandin before, during or after attack
12/04/1990US4975276 Polypeptide; viricides
12/04/1990CA2055619A1 Grf peptides
12/04/1990CA2018209A1 Use of a statin derivative in the treatment of eye complaints
12/04/1990CA1277323C Thiazolidinedione derivatives, their production and use
12/04/1990CA1277261C Monoclonal antibodies and hybridoma cells, to humain reinin: processes for their preparation and their applications
12/04/1990CA1277260C Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
12/04/1990CA1277237C Controlled release delivery system for macromolecules
12/04/1990CA1277232C Methods and compositions for the treatment of gastrointestinal disorders
12/03/1990WO1990015875A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof
12/03/1990WO1990015149A1 Vpt protein, vectors expressing this protein, cell products and assay methods
12/03/1990WO1990015076A2 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE
12/03/1990CA2056452A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof
12/03/1990CA2055591A1 Vpt protein, vectors expressing this protein, cell products and assay methods
12/02/1990CA2017466A1 Bone calcification factor
12/02/1990CA2017156A1 Preparation of fr115224 substance for parenteral administration
12/01/1990WO1990015140A1 Production of ibdv vp2 in highly immunogenic form
12/01/1990WO1990015056A1 Dopamine agonists
12/01/1990WO1990014835A1 Method to treat rheumatoid arthritis
12/01/1990CA2056995A1 Dopamine agonists
12/01/1990CA2056450A1 Method to treat rheumatoid arthritis
12/01/1990CA2017528A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
11/1990
11/30/1990CA2017803A1 Micropoteins, process for their preparation and use as medicaments thereof
11/29/1990WO1990014443A1 Co-expression of heteromeric receptors
11/29/1990WO1990014432A1 A human cytokine, interleukin-9
11/29/1990WO1990014430A1 A new method for tapping the immunological repertoire
11/29/1990WO1990014427A2 Multivalent repressor of gene function
11/29/1990WO1990014424A1 Method for isolating receptors having a preselected specificity
11/29/1990WO1990014418A1 Heparin-producing murine mastocytoma cell lines
11/29/1990WO1990014415A1 Recombinant dna method for production of parathyroid hormone
11/29/1990WO1990014363A1 Metalloproteinase inhibitor
11/29/1990WO1990014351A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor
11/29/1990WO1990014103A1 Polypeptide-antibody conjugate for inhibiting cell adhesion
11/29/1990WO1990014102A1 Thrombus-targeted complexes of plasminogen activator and fibrin fragments
11/29/1990WO1990014101A1 Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars
11/29/1990WO1990014099A2 Interleukin-2 tn treating birds
11/29/1990WO1990014097A1 Improved culture of human tumor-infiltrating lymphocytes by combining gas permeable bags and a primary culture container
11/29/1990WO1990014078A1 Method and composition for the treatment of thrombosis in a mammal
11/29/1990WO1990014073A1 Pharmaceutical preparation
11/29/1990WO1990014069A2 Keratinocyte autocrine factor
11/29/1990WO1990012804A3 Peptides having novel polar n-terminal groups
11/29/1990WO1990010448A3 Covalent conjugates of lipid and oligonucleotide
11/29/1990WO1990009162A3 Anaphylatoxin-receptor ligands
11/29/1990CA2057923A1 Co-expression of heteromeric receptors
11/29/1990CA2054764A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor
11/28/1990EP0399816A1 Purification and characterization of a glioma-derived growth factor
11/28/1990EP0399806A1 Fibronectin derivative
11/28/1990EP0399781A1 Stabilized calcitonin pharmaceutical composition
11/28/1990EP0399777A2 Hematopoietic growth factor derived from T lymphocytes and methods of use therefor
11/28/1990EP0399688A1 Trifluoroketopeptide derivatives useful as human leukocyte elastase inhibitors
11/28/1990EP0399685A1 Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13
11/28/1990EP0399666A1 Fusion proteins containing N-terminal fragments of human serum albumin
11/28/1990EP0399586A1 Aminoacylamino benzenesulfonamides useful for the treatment of glaucoma
11/28/1990EP0399556A1 Amino-substituted heterocycles as renin inhibitors
11/28/1990EP0399341A1 Aqueous composition for the parenteral nutrition
11/28/1990EP0399321A2 Gel filtration of heat treated factor VIII
11/28/1990EP0399257A1 Cell surface antigen that binds with L6 Monoclonal antibody
11/28/1990EP0399027A1 Biologically competent, virus inactivated albumin
11/28/1990EP0399024A1 ANTI-INTERLEUKINE 1$g(a) AND 1$g(b) MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1$g(a) AND 1$g(b) AND TO THERAPY
11/28/1990EP0398961A1 Polypeptide compounds having growth hormone releasing activity.
11/28/1990EP0398955A1 Diagnosis of retinoblastoma
11/28/1990EP0398925A1 Growth inhibiting agent and the use thereof.
11/28/1990EP0398879A1 Amino acid composition for parenteral nutritional support and the use thereof
11/28/1990EP0232284B1 New somatostatine derivatives
11/28/1990EP0114887B1 Polypeptide
11/28/1990CN1047340A Therapeutic agent
11/27/1990WO1990014356A1 Dominant negative members of the steroid/thyroid superfamily of receptors
11/27/1990US4973668 Variants of alpha 1-antitrypsin which are useful, in particular, as kallikrein inhibitors
11/27/1990US4973666 Measurement of bone resorption rates, hydroxypyridinium crosslinks
11/27/1990US4973578 Synthetic peptides derived from the alpha-subunit of human lycoprotein hormones
11/27/1990US4973577 Follicle stimulating hormone, increasing fertility
11/27/1990US4973555 Human serine protease gene
11/27/1990US4973479 Polypeptide; viricide, cell growth regulator
11/27/1990US4973478 Treating inflammation with hepatocyte stimulating factor interferon β2
11/27/1990CA2057049A1 Dominant negative members of the steroid/thyroid superfamily of receptors
11/27/1990CA2017543A1 Polyethylene glycol derivatives, process for preparing the same and modified protein
11/27/1990CA1277100C Glycopeptides, process for their preparation and their use
11/27/1990CA1277099C Peptide-substituted heterocyclic immunostimulants
1 ... 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 ... 3163